PZPengfei Zhao

Pengfei Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pengfei Zhao has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Junlong Zhao

    National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China

    6 shared publications
  • Rui Fang

    State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei, China

    3 shared publications
  • Yingjun Xia

    State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China

    3 shared publications
  • Li Zhang

    State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China

    2 shared publications
  • Yanqin Zhou

    Key Laboratory Preventive Veterinary of Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei, People’s Republic of China

    2 shared publications
  • Chaofei Wang

    State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China

    1 shared publication

Latest Publications

  • Open Access

    Prevalence and Heterogeneity of Swine Influenza Virus in China From 2010 to 2025: A Systematic Review and Meta‐Analysis

    by Xiutao Yang, Qingxia Gao, Zhaofang Xi, Pengfei Zhao, Junlong Zhao

    Background: Swine influenza virus (SIV) is endemic in China, threatening the swine industry and public health. This meta‐analysis estimated the national pooled prevalence of SIV (2010–2025) and identified key sources of heterogeneity. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines, six databases were searched, yielding 73 eligible studies with 411,930 samples. A random‐effects model pooled prevalence estimates, and subgroup analyses explored heterogeneity. Results: The pooled SIV prevalence was 30.3% (95% confidence interval [CI]: 24.5%–36.4%) with extreme heterogeneity ( I 2 = 100%, p < 0.001). Key drivers included diagnostic method (serological: 37.1% vs. virological: 2.6%), geography (Southwest China: 54.3%), and viral genotype (H1 > H3). Sensitivity analysis confirmed robustness, but publication bias (Egger’s test, p = 0.0009) suggests potential overestimation. Conclusion: SIV is widespread in China but exhibits marked spatiotemporal and methodological variability. A single national prevalence figure is insufficient for risk assessment. Surveillance and control strategies must be targeted and context‐specific. This study provides a critical, albeit potentially overestimated, epidemiological baseline for evidence‐based interventions.

  • Open Access

    Babesia duncani Pyruvate Kinase Inhibitor Screening and Identification of Key Active Amino Acid Residues

    by Fangjie Li, Pengfei Zhao, Sen Wang, Wanxin Luo, Yingjun Xia, Dongfang Li, Lan He, Junlong Zhao

    Babesia duncani (B. duncani), a protozoan parasite prevalent in North America, is a significant threat for human health. Given the regulatory role of pyruvate kinase I (PyK I) in glycolytic metabolism flux and ATP generation, PyK I has been considered the target for drug intervention for a long time. In this study, B. duncani PyK I (BdPyK I) was successfully cloned, expressed, and purified. Polyclonal antibodies were confirmed to recognize the native BdPyK I protein (56 kDa) using Western blotting. AlphaFold software predicted the three-dimensional structure of BdPyK I, and molecular docking with small molecules was conducted to identify potential binding sites of inhibitor on BdPyK I. Moreover, inhibitory effects of six inhibitors (tannic acid, apigenin, shikonin, PKM2 inhibitor, rosiglitazone, and pioglitazone) on BdPyK I were examined under the optimal enzymatic conditions of 3 mM PEP and 3 mM ADP, and significant activity reduction was found. Enzyme kinetics and growth inhibition assays further confirmed the reliability of these inhibitors, with PKM2 inhibitor, tannic acid, and apigenin exhibiting the highest selectivity index as specific inhibitors for B. duncani. Subsequently, key amino acid residues were mutated in both BdPyK I and Homo sapiens pyruvate kinase I (HPyK I), and two differential amino acid residues (isoleucine and phenylalanine) were identified between HPyK I and BdPyK I through PyK activity detection experiments. These findings lay foundation for understanding the role of PyK I in the growth and development of B. duncani, providing insights for babesiosis prevention and drug development.


  • Open Access

    Isolation, Identification, Genomic Diversity, and Antimicrobial Resistance Analysis of Streptococcus suis in Hubei Province of China from 2021 to 2023

    by Yingjun Xia, Zhaoyang Wang, Yanli Hu, Pengfei Zhao, Jianhai Li, Li Zhang, Rui Fang, Junlong Zhao

    Streptococcus suis (S. suis) is a zoonotic pathogen capable of causing severe diseases in humans and pigs, including meningitis, sepsis, polyserositis, arthritis, and endocarditis. This study aimed to investigate the biological characteristics of 19 strains of S. suis isolated from diseased pigs in Hubei Province between 2021 and 2023. Through bioinformatics analysis, we investigated the serotype, MLST, pan-genome characteristics, SNP, AMR, and ICE of the 19 S. suis isolates. Among the 19 S. suis strains, ten serotypes were identified, and serotype 9 was the most prevalent (21.05%). Ten new alleles and nine new sequence types (STs) were discovered, with ST28 and ST243 emerging as the predominant STs. The results of the pan-genomic analysis of S. suis indicate that there are 943 core genes, 2259 shell genes, and 5663 cloud genes. Through SNP evolutionary analysis, we identified a strong genetic similarity between SS31 and the reference genome P1/7. The analysis of antibiotic resistance genes revealed widespread presence of erm(B) and tet(O) genes among 19 strains of S. suis. This association may be linked to the high resistance of S. suis to lincosamides, macrolides, and tetracyclines. Integrative and conjugative elements (ICEs) and integrative and mobilizable elements (IMEs) were identified in 16 strains, with a carriage rate of 84.21%, and resistance genes were identified within the ICE/IME elements of 8 strains. Antimicrobial susceptibility testing revealed that all strains showed sensitivity to vancomycin and lincomycin but resistance to tilmicosin, tiamulin, amoxicillin, and doxycycline. This study contributes to our understanding of the genomic diversity of S. suis in Hubei Province of China, providing essential data for the comprehensive prevention and control of S. suis infections in China.


  • Seroprevalence Investigation of Classic Swine Fever Virus Before, During, and After African Swine Fever Virus Outbreak in Some Provinces of China from 2017 to 2021

    by Pengfei Zhao, Chaofei Wang, Yingjun Xia, Yanli Hu, Rui Fang, Junlong Zhao

    Classic swine fever is a severe infectious and fatal disease in pigs caused by the classic swine fever virus (CSFV). Surveillance and investigation for CSFV seroprevalence contribute to knowing the immune efficiency of CSFV vaccines and reflect health status of swine herd, especially since the African swine fever virus (ASFV) outbreak in China in 2018. A total of 40,489 pig serum samples with related descriptive variables were obtained from 12 provinces and 2 cities of China from December 2017 to May 2021, covering before, during, and after three periods of ASFV outbreak. Pearson chi-square test and multivariable logistic regression analysis were used to identify impact factors related to variations in CSFV seroprevalence. Total CSFV seroprevalence was 60.40% (95% confidence interval: 59.92–60.88). Seroprevalence and antibody blocking rate mean of CSFV before outbreak of ASFV in China are higher and change gently compared with that after outbreak of ASFV. Serum collected from “summer and autumn,” “north, southwest and northwest of China,” “pig farm located in hill or mountain,” “ period before outbreak of ASFV,” “PRRSV negative farm,” and “replacement gilts, multiparous sows and boars” show high seroprevalence of CSFV. These results show trends in prevalence of CSFV antibody in recent years in China, especially when ASFV entered China. Identified impact factors provide references for improving immune efficiency of CSFV vaccine and benefit for prevention of CSFV.


  • Evaluation of immunoprotective effects of recombinant protein and DNA vaccine based on Eimeria tenella surface antigen 16 and 22 in vivo

    by Pengfei Zhao, Chaofei Wang, Jun Ding, Chengfeng Zhao, Yingjun Xia, Yanli Hu, Li Zhang, Yanqin Zhou, Junlong Zhao, Rui Fang

    Coccidiosis triggered by Eimeria tenella is accompanied by haemorrhagic caecum and high morbidity. Vaccines are preferable choices to replace chemical drugs against coccidiosis. Surface antigens of apicomplexan parasites can adhere to host cells during the infection process. Therefore, truncated fragments coding E. tenella surface antigen 16 (EtSAG16) and 22 (EtSAG22) were cloned into pET-28a prokaryotic vector to express recombinant protein 16 (rEtSAG16) and 22 (rEtSAG22), respectively. Likewise, pEGFP-N1-EtSAG16 and pEGFP-N1-EtSAG22 plasmids were constructed using pEGFP-N1 eukaryotic vector. Further, pEGFP-N1-EtSAG4-16-22 multiple gene plasmid carrying EtSAG4, 16 and 22 were designed as cocktail vaccines to study integral immunoprotective effects. Western blot and RT-PCR (reverse transcription) assay were performed to verify expressions of EtSAG16 and 22 genes. Immunoprotective effects of recombinant protein or DNA vaccine were evaluated using different doses (50 or 100 μg) in vivo. All chickens in the vaccination group showed higher cytokine concentration (IFN-γ and IL-17), raised IgY antibody level, increased weight gain, lower caecum lesion score and reduced oocyst shedding compared with infection control groups (p < 0.05). The highest anticoccidial index (ACI) value 173.11 was from the pEGFP-N1-EtSAG4-16-22 plasmid (50 μg) group. In conclusion, EtSAG16 and 22 might be alternative candidate genes for generating vaccines against E. tenella infection.